ArticleOncology and therapy2021

Daratumumab Monotherapy for Relapsed or Refractory Multiple Myeloma: Results of an Early Access Treatment Protocol in Europe and Russia.

Gordon Cook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.